Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

HSV-1 replication, ocular disease and reactivations from latency are restricted unilaterally after inoculation of virus into the lip.

Poccardi N, Rousseau A, Haigh O, Takissian J, Naas T, Deback C, Trouillaud L, Issa M, Roubille S, Juillard F, Efstathiou S, Lomonte P, Labetoulle M.

J Virol. 2019 Sep 25. pii: JVI.01586-19. doi: 10.1128/JVI.01586-19. [Epub ahead of print]

PMID:
31554680
2.

Effectiveness and easiness of adherence to behavioural guidelines for diet and lifestyle changes for cholesterol-lowering: the Increasing Adherence of Consumers to Diet & Lifestyle Changes to Lower (LDL) Cholesterol (ACT) randomised controlled trial.

Magriplis E, Sialvera TE, Papadopoulou A, Efstathiou SP, Trautwein EA, Goumas G, Dimakopoulos I, Papavasiliou K, Koutsouri A, Zampelas A.

J Hum Nutr Diet. 2019 Oct;32(5):607-618. doi: 10.1111/jhn.12667. Epub 2019 May 27.

PMID:
31134707
3.

Structured advice provided by a dietitian increases adherence of consumers to diet and lifestyle changes and lowers blood low-density lipoprotein (LDL)-cholesterol: the Increasing Adherence of Consumers to Diet & Lifestyle Changes to Lower (LDL) Cholesterol (ACT) randomised controlled trial.

Sialvera TE, Papadopoulou A, Efstathiou SP, Trautwein EA, Ras RT, Kollia N, Farajian P, Goumas G, Dimakopoulos I, Papavasiliou K, Koutsouri A, Zampelas A.

J Hum Nutr Diet. 2018 Apr;31(2):197-208. doi: 10.1111/jhn.12508. Epub 2017 Sep 11.

PMID:
28891084
4.

Short-term effects of Mediterranean-type diet intervention on soluble cellular adhesion molecules in subjects with abdominal obesity.

Rallidis LS, Kolomvotsou A, Lekakis J, Farajian P, Vamvakou G, Dagres N, Zolindaki M, Efstathiou S, Anastasiou-Nana M, Zampelas A.

Clin Nutr ESPEN. 2017 Feb;17:38-43. doi: 10.1016/j.clnesp.2016.11.002. Epub 2016 Dec 23.

PMID:
28361746
5.

Cell autonomous regulation of herpes and influenza virus infection by the circadian clock.

Edgar RS, Stangherlin A, Nagy AD, Nicoll MP, Efstathiou S, O'Neill JS, Reddy AB.

Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):10085-90. doi: 10.1073/pnas.1601895113. Epub 2016 Aug 15.

6.

The HSV-1 Latency-Associated Transcript Functions to Repress Latent Phase Lytic Gene Expression and Suppress Virus Reactivation from Latently Infected Neurons.

Nicoll MP, Hann W, Shivkumar M, Harman LE, Connor V, Coleman HM, Proença JT, Efstathiou S.

PLoS Pathog. 2016 Apr 7;12(4):e1005539. doi: 10.1371/journal.ppat.1005539. eCollection 2016 Apr.

7.

Introduction-Grand Challenges and small steps.

De Grandis G, Efstathiou S.

Stud Hist Philos Biol Biomed Sci. 2016 Apr;56:39-47. doi: 10.1016/j.shpsc.2015.11.009. Epub 2015 Dec 22.

PMID:
26705674
8.

Is it possible to give scientific solutions to Grand Challenges? On the idea of grand challenges for life science research.

Efstathiou S.

Stud Hist Philos Biol Biomed Sci. 2016 Apr;56:48-61. doi: 10.1016/j.shpsc.2015.10.009. Epub 2015 Dec 11.

PMID:
26698954
9.

Analyses of herpes simplex virus type 1 latency and reactivation at the single cell level using fluorescent reporter mice.

Proença JT, Nelson D, Nicoll MP, Connor V, Efstathiou S.

J Gen Virol. 2016 Mar;97(3):767-77. doi: 10.1099/jgv.0.000380. Epub 2015 Dec 22.

10.

Development of Lentivirus-Based Reference Materials for Ebola Virus Nucleic Acid Amplification Technology-Based Assays.

Mattiuzzo G, Ashall J, Doris KS, MacLellan-Gibson K, Nicolson C, Wilkinson DE, Harvey R, Almond N, Anderson R, Efstathiou S, Minor PD, Page M.

PLoS One. 2015 Nov 12;10(11):e0142751. doi: 10.1371/journal.pone.0142751. eCollection 2015.

11.

In memoriam--Richard M. Elliott (1954-2015).

Brennan B, Weber F, Kormelink R, Schnettler E, Bouloy M, Failloux AB, Weaver SC, Fazakerley JK, Fragkoudis R, Harris M, Barr JN, Palese P, García-Sastre A, Dalziel RG, Dutia BM, Lowen AC, Steel J, Randall RE, Paul Duprex W, Rice CM, Tesh RB, Murphy FA, Ebihara H, Vasconcelos PF, Nunes MR, Fooks AR, Smith GL, Goodfellow I, Pappu HR, Lamb RA, Paterson RG, Higgs S, Vanlandingham DL, Dietzgen RG, Stephen Lodmell J, Nichol ST, Daly J, Ullman DE, Plyusnin A, Plyusnina A, Efstathiou S, Hewson R, Tordo N, Cherry S, Boutell C, Hosie MJ, Murcia PR, Neil JC, Palmarini M, Patel AH, Willett BJ, Kohl A, McLauchlan J.

J Gen Virol. 2015 Aug;96(8):1975-8. doi: 10.1099/jgv.0.000241. No abstract available.

12.

Widespread disruption of host transcription termination in HSV-1 infection.

Rutkowski AJ, Erhard F, L'Hernault A, Bonfert T, Schilhabel M, Crump C, Rosenstiel P, Efstathiou S, Zimmer R, Friedel CC, Dölken L.

Nat Commun. 2015 May 20;6:7126. doi: 10.1038/ncomms8126.

13.

Catch-up growth in low-birthweight infants: friend or foe?

Efstathiou SP.

Paediatr Int Child Health. 2015 May;35(2):81-2. doi: 10.1179/2046905515Y.0000000011. Epub 2015 Apr 6. No abstract available.

PMID:
25844570
14.

BAFF receptor deficiency limits gammaherpesvirus infection.

Frederico B, May JS, Efstathiou S, Stevenson PG.

J Virol. 2014 Apr;88(8):3965-75. doi: 10.1128/JVI.03497-13. Epub 2014 Feb 5.

15.

A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication.

Griffiths SJ, Koegl M, Boutell C, Zenner HL, Crump CM, Pica F, Gonzalez O, Friedel CC, Barry G, Martin K, Craigon MH, Chen R, Kaza LN, Fossum E, Fazakerley JK, Efstathiou S, Volpi A, Zimmer R, Ghazal P, Haas J.

PLoS Pathog. 2013;9(8):e1003514. doi: 10.1371/journal.ppat.1003514. Epub 2013 Aug 8.

16.
17.

Herpes simplex virus 1 targets the murine olfactory neuroepithelium for host entry.

Shivkumar M, Milho R, May JS, Nicoll MP, Efstathiou S, Stevenson PG.

J Virol. 2013 Oct;87(19):10477-88. doi: 10.1128/JVI.01748-13. Epub 2013 Jul 31.

18.

A heparan-dependent herpesvirus targets the olfactory neuroepithelium for host entry.

Milho R, Frederico B, Efstathiou S, Stevenson PG.

PLoS Pathog. 2012;8(11):e1002986. doi: 10.1371/journal.ppat.1002986. Epub 2012 Nov 1.

19.

Permissive and restricted virus infection of murine embryonic stem cells.

Wash R, Calabressi S, Franz S, Griffiths SJ, Goulding D, Tan EP, Wise H, Digard P, Haas J, Efstathiou S, Kellam P.

J Gen Virol. 2012 Oct;93(Pt 10):2118-30. doi: 10.1099/vir.0.043406-0. Epub 2012 Jul 18.

20.

An overlapping protein-coding region in influenza A virus segment 3 modulates the host response.

Jagger BW, Wise HM, Kash JC, Walters KA, Wills NM, Xiao YL, Dunfee RL, Schwartzman LM, Ozinsky A, Bell GL, Dalton RM, Lo A, Efstathiou S, Atkins JF, Firth AE, Taubenberger JK, Digard P.

Science. 2012 Jul 13;337(6091):199-204. doi: 10.1126/science.1222213. Epub 2012 Jun 28.

21.

Influence of herpes simplex virus 1 latency-associated transcripts on the establishment and maintenance of latency in the ROSA26R reporter mouse model.

Nicoll MP, Proença JT, Connor V, Efstathiou S.

J Virol. 2012 Aug;86(16):8848-58. doi: 10.1128/JVI.00652-12. Epub 2012 Jun 13.

22.

The Nazi cosmetic: medicine in the service of beauty.

Efstathiou S.

Stud Hist Philos Biol Biomed Sci. 2012 Sep;43(3):634-42. doi: 10.1016/j.shpsc.2012.05.002. Epub 2012 Jun 8.

PMID:
22683496
23.

Metabolic syndrome in adolescence: can it be predicted from natal and parental profile? The Prediction of Metabolic Syndrome in Adolescence (PREMA) study.

Efstathiou SP, Skeva II, Zorbala E, Georgiou E, Mountokalakis TD.

Circulation. 2012 Feb 21;125(7):902-10. doi: 10.1161/CIRCULATIONAHA.111.034546. Epub 2012 Jan 12.

PMID:
22247492
24.

Adherence to Mediterranean diet and close dietetic supervision increase total dietary antioxidant intake and plasma antioxidant capacity in subjects with abdominal obesity.

Kolomvotsou AI, Rallidis LS, Mountzouris KC, Lekakis J, Koutelidakis A, Efstathiou S, Nana-Anastasiou M, Zampelas A.

Eur J Nutr. 2013 Feb;52(1):37-48. doi: 10.1007/s00394-011-0283-3. Epub 2012 Jan 12.

PMID:
22237557
25.

The molecular basis of herpes simplex virus latency.

Nicoll MP, Proença JT, Efstathiou S.

FEMS Microbiol Rev. 2012 May;36(3):684-705. doi: 10.1111/j.1574-6976.2011.00320.x. Epub 2012 Jan 10. Review.

26.

The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization.

Wuest T, Zheng M, Efstathiou S, Halford WP, Carr DJ.

PLoS Pathog. 2011 Oct;7(10):e1002278. doi: 10.1371/journal.ppat.1002278. Epub 2011 Oct 6.

27.

An investigation of herpes simplex virus promoter activity compatible with latency establishment reveals VP16-independent activation of immediate-early promoters in sensory neurones.

Proença JT, Coleman HM, Nicoll MP, Connor V, Preston CM, Arthur J, Efstathiou S.

J Gen Virol. 2011 Nov;92(Pt 11):2575-85. doi: 10.1099/vir.0.034728-0. Epub 2011 Jul 13.

28.

Molecular basis of HSV latency and reactivation.

Preston CM, Efstathiou S.

In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K, editors. Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge: Cambridge University Press; 2007. Chapter 33.

29.

Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro.

De Regge N, Van Opdenbosch N, Nauwynck HJ, Efstathiou S, Favoreel HW.

PLoS One. 2010 Sep 29;5(9). pii: e13076. doi: 10.1371/journal.pone.0013076.

30.

Vaccination against a hit-and-run viral cancer.

Stevenson PG, May JS, Connor V, Efstathiou S.

J Gen Virol. 2010 Sep;91(Pt 9):2176-85. doi: 10.1099/vir.0.023507-0. Epub 2010 Jun 23.

31.

Staple line reinforcement in laparoscopic bariatric surgery: does it actually make a difference? A systematic review and meta-analysis.

Giannopoulos GA, Tzanakis NE, Rallis GE, Efstathiou SP, Tsigris C, Nikiteas NI.

Surg Endosc. 2010 Nov;24(11):2782-8. doi: 10.1007/s00464-010-1047-5. Epub 2010 Apr 16. Review.

PMID:
20396908
32.

Fever of unknown origin: discrimination between infectious and non-infectious causes.

Efstathiou SP, Pefanis AV, Tsiakou AG, Skeva II, Tsioulos DI, Achimastos AD, Mountokalakis TD.

Eur J Intern Med. 2010 Apr;21(2):137-43. doi: 10.1016/j.ejim.2009.11.006. Epub 2009 Dec 6.

PMID:
20206887
33.

Angiomyofibroblastoma of the spermatic cord: a case report.

Tzanakis NE, Giannopoulos GA, Efstathiou SP, Rallis GE, Nikiteas NI.

J Med Case Rep. 2010 Mar 4;4:79. doi: 10.1186/1752-1947-4-79.

34.

Prognostic significance of p53 and Ki67 proteins expression in Greek gastric cancer patients.

Tzanakis NE, Peros G, Karakitsos P, Giannopoulos GA, Efstathiou SP, Rallis G, Tsigris C, Kostakis A, Nikiteas NI.

Acta Chir Belg. 2009 Oct;109(5):606-11.

PMID:
19994803
35.

Characterization of a novel wood mouse virus related to murid herpesvirus 4.

Hughes DJ, Kipar A, Milligan SG, Cunningham C, Sanders M, Quail MA, Rajandream MA, Efstathiou S, Bowden RJ, Chastel C, Bennett M, Sample JT, Barrell B, Davison AJ, Stewart JP.

J Gen Virol. 2010 Apr;91(Pt 4):867-79. doi: 10.1099/vir.0.017327-0. Epub 2009 Nov 25.

36.

Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4.

Stevenson PG, Simas JP, Efstathiou S.

J Gen Virol. 2009 Oct;90(Pt 10):2317-30. doi: 10.1099/vir.0.013300-0. Epub 2009 Jul 15. Review.

PMID:
19605591
37.

Close adherence to a Mediterranean diet improves endothelial function in subjects with abdominal obesity.

Rallidis LS, Lekakis J, Kolomvotsou A, Zampelas A, Vamvakou G, Efstathiou S, Dimitriadis G, Raptis SA, Kremastinos DT.

Am J Clin Nutr. 2009 Aug;90(2):263-8. doi: 10.3945/ajcn.2008.27290. Epub 2009 Jun 10.

PMID:
19515732
38.

Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population.

Efstathiou SP, Skeva II, Dimas C, Panagiotou A, Parisi K, Tzanoumis L, Kafouri A, Bakratsas K, Mountokalakis TD.

Atherosclerosis. 2009 Aug;205(2):632-6. doi: 10.1016/j.atherosclerosis.2009.01.022. Epub 2009 Jan 24.

PMID:
19217624
39.

In vivo imaging of murid herpesvirus-4 infection.

Milho R, Smith CM, Marques S, Alenquer M, May JS, Gillet L, Gaspar M, Efstathiou S, Simas JP, Stevenson PG.

J Gen Virol. 2009 Jan;90(Pt 1):21-32. doi: 10.1099/vir.0.006569-0.

40.

A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones.

Proença JT, Coleman HM, Connor V, Winton DJ, Efstathiou S.

J Gen Virol. 2008 Dec;89(Pt 12):2965-74. doi: 10.1099/vir.0.2008/005066-0.

41.

Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICP0-mediated de-repression.

Coleman HM, Connor V, Cheng ZS, Grey F, Preston CM, Efstathiou S.

J Gen Virol. 2008 Jan;89(Pt 1):68-77.

42.

Direct acoustic profiling of DNA hybridisation using HSV type 1 viral sequences.

Uludağ Y, Li X, Coleman H, Efstathiou S, Cooper MA.

Analyst. 2008 Jan;133(1):52-7. Epub 2007 Sep 21.

PMID:
18087613
43.
44.
45.

Arterial stiffness: determinants and relationship to the metabolic syndrome.

Achimastos AD, Efstathiou SP, Christoforatos T, Panagiotou TN, Stergiou GS, Mountokalakis TD.

Angiology. 2007 Feb-Mar;58(1):11-20.

PMID:
17351153
46.

Prognostic significance of plasma resistin levels in patients with atherothrombotic ischemic stroke.

Efstathiou SP, Tsiakou AG, Tsioulos DI, Panagiotou TN, Pefanis AV, Achimastos AD, Mountokalakis TD.

Clin Chim Acta. 2007 Mar;378(1-2):78-85. Epub 2006 Nov 7.

PMID:
17173885
47.

Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts.

Maillet S, Naas T, Crepin S, Roque-Afonso AM, Lafay F, Efstathiou S, Labetoulle M.

J Virol. 2006 Sep;80(18):9310-21.

48.

Pseudohyperkalemia in serum: the phenomenon and its clinical magnitude.

Sevastos N, Theodossiades G, Efstathiou S, Papatheodoridis GV, Manesis E, Archimandritis AJ.

J Lab Clin Med. 2006 Mar;147(3):139-44.

PMID:
16503244
49.

Pseudohyperkalemia in patients with increased cellular components of blood.

Sevastos N, Theodossiades G, Savvas SP, Tsilidis K, Efstathiou S, Archimandritis AJ.

Am J Med Sci. 2006 Jan;331(1):17-21.

PMID:
16415658
50.

Immune mechanisms in murine gammaherpesvirus-68 infection.

Stevenson PG, Efstathiou S.

Viral Immunol. 2005;18(3):445-56. Review.

PMID:
16212523

Supplemental Content

Loading ...
Support Center